Insider Transactions in Q1 2021 at Clearside Biomedical, Inc. (CLSD)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
3,370
-0.78%
|
$6,740
$2.82 P/Share
|
|
Mar 12
2021
|
Nancy J Hutson |
BUY
Open market or private purchase
|
Direct |
5,000
+33.33%
|
$15,000
$3.1 P/Share
|
|
Mar 02
2021
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
6,000
-1.36%
|
$18,000
$3.37 P/Share
|
|
Feb 10
2021
|
Clay Thorp |
SELL
Open market or private sale
|
Indirect |
32,873
-0.95%
|
$131,492
$4.43 P/Share
|
|
Jan 18
2021
|
Thomas Ciulla Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,125
+28.95%
|
-
|
|
Jan 18
2021
|
Charles A. Deignan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96,360
+23.02%
|
-
|
|
Jan 18
2021
|
George M Lasezkay CEO |
BUY
Grant, award, or other acquisition
|
Direct |
140,250
+24.19%
|
-
|
|
Jan 06
2021
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
350,750
+9.04%
|
$701,500
$2.85 P/Share
|